Skip to main content
Caplight Logo









DiRx

DiRx

Private
East Brunswick, New JerseyHealthcare & Life Scienceshttps://dirxhealth.com/homepage

Last Round

Series A

Dec 28, 2021

Total Funding Raised

$15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DiRx operates in Healthcare & Life Sciences and is based in East Brunswick, New Jersey. Its latest recorded funding round was a Series A round in December 2021.

DiRx is a digital health company that operates an online pharmacy platform providing affordable, FDA-approved generic medications directly to consumers without the need for insurance.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, D2C Brands, Pharma Supply Chain

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

DiRx Comparables

Compare DiRx with similar companies based on industry and business-model similarity.

DiRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ScriptCo Pharmacy
89%
Mark Cuban Cost Plus Drug Company
88%
Honeybee Health
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

DiRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 28, 2021
SeedSep 21, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Satish Srinivasan

Founder & Chief Executive Officer

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 18, 2026

    Headcount grew 19% QoQ (from 26 to 31 employees)

  • Aug 27, 2026

    Grew 28% QoQ, from 25 to 32 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

DiRx Filings

Explore SEC and related filing metadata, where available.

DiRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about DiRx's valuation, stock price, and market status.

Is DiRx a public or private company?

DiRx is a private company.

What is the current stock price of DiRx?

DiRx is a private company, so its shares have no public market price. Caplight tracks DiRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is DiRx worth (valuation)?

Valuation information for DiRx is not publicly available.

Can I buy DiRx stock?

DiRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was DiRx's last funding round?

DiRx's most recent funding round was Series A on December 28, 2021.

Who are the main investors in DiRx?

Investor information for DiRx is not publicly disclosed.

Will DiRx IPO soon?

No public IPO plans have been announced for DiRx.

How can I track DiRx secondary market activity?

Caplight tracks bids, offers, and trades in DiRx's shares on secondary markets.

Firmographic Details

HeadquartersEast Brunswick, New Jersey
Employee Range31
Year Founded2020
Last FundingDec 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?